Novartis AG (XSWX:NOVNEE) Common Stock: CHF579 Mil (As of Mar. 2026)


XSWX:NOVNEE Novartis AG XSWX:NOVNEE
81 GF Score
Price CHF119.30
GF Value CHF99.56
! 7 Warning Signs
View Full Analysis

What is Novartis AG Common Stock?

Novartis AG XSWX:NOVNEE -0.52% 81 Common Stock is CHF579 Mil as of Mar. 2026. GuruFocus rates XSWX:NOVNEE with a GF Score™ of 81/100 and a GF Value™ of CHF99.56. The stock has 7 warning signs investors should review.

Novartis AG's quarterly common stock increased from Sep. 2025 (CHF610 Mil) to Dec. 2025 (CHF610 Mil) but then declined from Dec. 2025 (CHF610 Mil) to Mar. 2026 (CHF579 Mil).

Novartis AG's annual common stock declined from Dec. 2023 (CHF713 Mil) to Dec. 2024 (CHF707 Mil) and declined from Dec. 2024 (CHF707 Mil) to Dec. 2025 (CHF610 Mil).

Novartis AG Common Stock Historical Data

* Premium members only.

The historical data trend for Novartis AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG Common Stock Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 829.82 829.12 713.46 707.04 610.43

Novartis AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 676.84 622.91 609.81 610.43 579.45
XSWX:NOVNEE
81GF Score
Novartis AG XSWX:NOVNEE
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novartis AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of CHF579 Mil mean?
Novartis AG (XSWX:NOVNEE) has a Common Stock of CHF579 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Novartis AG and its competitors.
Is Novartis AG's Common Stock too high?
Novartis AG's current Common Stock is CHF579 Mil. Overall, Novartis AG has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's Common Stock compare to LLY and JNJ?
Novartis AG's Common Stock of CHF579 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Novartis AG and its competitors. Novartis AG's current Common Stock is CHF579 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Novartis AG (XSWX:NOVNEE) has a current Common Stock of CHF579 Mil. The stock's GF Value™ is CHF99.56, compared to a current price of CHF119.30 — trading 19.8% above its estimated fair value. The current Common Stock is CHF579 Mil. Novartis AG's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Novartis AG (XSWX:NOVNEE), the current Common Stock is CHF579 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novartis AG (XSWX:NOVNEE) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of CHF119.30 is trading 19.8% above its estimated GF Value™ of CHF99.56.

Key valuation signals for XSWX:NOVNEE:

  • Common Stock: CHF579 Mil
  • GF Value™: CHF99.56 vs. price of CHF119.30 (19.8% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the XSWX:NOVNEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
81GF Score

Get the complete analysis for XSWX:NOVNEE

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF119.30
Price
CHF99.56
GF Value